What you don’t know about how drugs are tested and marketed could hurt you, says author Ben Goldacre in his book Bad Pharma
Two cases could trigger dramatic changes in the way medications and therapies are regulated.
In a new book, “Bad Pharma,” British columnist Dr. Ben Goldacre lays out all the clever ways in which the pharmaceutical industry is getting bad drugs onto shelves
Why the Congressman’s recent diagnosis of bipolar 2 has a history of controversy
A Q&A with the author of Pharmageddon about how the pharmaceutical industry has co-opted medicine.
Pharmaceutical companies have recently paid out the largest legal settlements in U.S. history — including the largest criminal fines ever imposed on corporations — for illegally marketing antipsychotic drugs.
The New York Times Magazine on Sunday included a rather befuddling column by departing writer Virginia Heffernan.
Welcome to Mind Reading, Healthland’s new series of talks with authors of “brainy” books.
If you’ve ever worried that pharmaceutical companies have too much sway when it comes to determining your treatment, today’s news won’t help quell your fears.
The New York Times reports that a large pharmaceutical developer hired ghostwriters to “play a major role in producing” 26 scientific papers that support hormone replacement …